Advertisement

Topics

US pharma rejects ICER report into value of abuse-deterrent opioids

13:10 EDT 10 Aug 2017 | thePharmaLetter

The industry-funded Alliance for Patient Access has dismissed a recently finalized ICER report critical…

Original Article: US pharma rejects ICER report into value of abuse-deterrent opioids

NEXT ARTICLE

More From BioPortfolio on "US pharma rejects ICER report into value of abuse-deterrent opioids"

Quick Search
Advertisement
 

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.